公司资料
Shockwave Medical 股价、新闻与催化剂
- 股票代码:
- SWAV
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
Current closing-price context is not available for SWAV.
公司概览
业务概览
Shockwave Medical was a medical technology company focused on intravascular lithotripsy for cardiovascular disease before being acquired by Johnson & Johnson. Its platform changed how clinicians approached calcium-related vessel treatment.
所在地与行业分类
Shockwave was headquartered in the United States and listed on NASDAQ before the acquisition. It sat in high-growth cardiovascular medtech rather than biotech.
商业模式特征
The company generated value through procedure adoption, product expansion, and the widening use of its lithotripsy platform. Investors watched procedural growth, international adoption, and system penetration.
生物医药行业定位
Shockwave was outside biotech but was one of the most important procedure-driven medtech growth names. Because it has been acquired, it is now a historical reference point rather than a live public company.
未来催化剂
- Shockwave’s catalyst story is still intravascular lithotripsy adoption and how the franchise is being integrated into the broader commercial footprint. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。